Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Are Insiders Buying Or Selling Dbv Tech Dbvt Stock Price At 20.90 Down 2.34 20260410 What Upcoming Catalysts Matter For Astec Aste Stock Price At 55.06 Down 1.98 20260402 Will Chunghwa Tel Cht Stock Miss Expectations Price At 42.53 Up 0.28 20260406 Is Neuberger Nbxg Stock In A Buying Zone Price At 13.55 Up 2.57 20260408 Is Tidewater Tdw Stock Near Resistance Price At 86.25 Up 1.09 20260407 JACK Jack In Q1 earnings miss estimates by 6 as revenue drops 68 yearoveryear Why AbbVie ABBV is trading below its true worth Marginal Loss 20260508 OKLO Oklo Inc posts wider Q4 2025 loss than expected shares rise 405 percent on positive longterm investor sentiment NXPI NXP Semiconductors NV reports narrow Q4 2025 earnings beat shares gain 108 percent in todays trading CN Energy CNEY Stock Worth Buying Investors Pile In 20260420 What Consol Water CWCO is doing that could pay off big later Near Highs 20260511 The March 2026 industrial profit data reveals several critical developments for investors to monitor AIO Virtus AI emphasizes longterm AI sector upside in its newly released quarterly earnings report Are funds investing in Okta OKTA stock Okta posts 42 EPS beat on strong revenue Netflix Inc NFLX Strong Fundamental Trajectory Offset by NearTerm Headwinds Limiting Upside at Current Valuation HLIO Helios Technologies Q4 beats estimates by 106 yet shares decline 262 despite revenue growth COO Cooper Q1 earnings beat estimates by 57 yet stock flat despite 51 revenue growth BCO Brinks posts 14 EPS beat in Q1 but shares dip 12 as investors seek revenue clarity KMDA Kamada reports Q4 2025 earnings miss yet shares post small gains in todays trading Is Cadiz CDZIP Still a Buy After 159 Rally 20260515 Waymo Voluntary Recall Affects Thousands of Robotaxis After San Antonio Creek Incident Iconic UK Favorite Could Return as Electric Vehicle Manufacturer Plans Seven New European Models Nigel Farages 14m House Financing Faces Accounting Scrutiny Amid Donation Discrepancies Apex Treas APXTU Stalls at 1014 Breakout or Breakdown 20260514 Lyft LYFT Falls 138 Watching 1253 Support 20260519 ANI Pharma ANIP Climbs 170 Resistance at 8331 in Focus 20260518 Hamilton HG Q1 2026 Earnings Beat Revenue NA EPS 131 Intrepid Potash IPI Stock Analysis RangeBound Near 4036 20260521 GameStops Potential eBay Acquisition Raises Credit and Valuation Concerns Carnival CCL Q1 2026 Earnings Why the Beat Matters Why KB KB Just Surged 097 Key Levels Ahead 20260520 Japans Megabanks Report Record Profits Amid Rising Credit and Geopolitical Risks Barclays Reports 18 Profit Increase Amid Upward Revision of Income Guidance Mr Yaki Razmovich Teaching Financial Literacy Through Everyday Purchases Endurance Technologies IPO Opens Key Details and Market Outlook Prediction Market Investments Continue Despite Regulatory Uncertainty Earnings Calls Suggest GGR Q1 2026 Earnings EPS Reports 048 as Gogoro Navigates Challenges Independent Bank Corp INDB Q1 2026 Earnings Marginal EPS Miss Within Expectations SFL Q1 2026 Earnings Stunning EPS Surprise of 1880 Despite Negative Stock Reaction GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly MCHB Q1 2026 Earnings Profit Miss Sends Shares Lower Amid Margin Pressures ScanSource SCSC Rises 195 as Shares Test Near Support Hologic Inc Holds Steady at 7601 as Traders Assess Support and Resistance Levels Lantheus Holdings LNTH Surges 9 Key Levels and Momentum Drivers Super Group SGHC Shares Dip 263 as Stock Holds Near Key Support Level UVV Universal Corporation posts 319 percent Q1 2026 EPS miss yet shares gain 125 percent today How TechPrecision TPCS balances growth with profitability Touches Low 20260505 What to expect when John PDT reports earnings PDT Q2 Earnings John Fund Announces Distribution Amid Rate Environment How Vyome Holdings HIND compares to the market average Weakens 20260508 Vertex Pharmaceuticals VRTX Robust Casgevy Early Launch Metrics Spark Counterintuitive Selloff for CoCommercialization Partner CRISPR Therapeutics